Title : Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes.

Pub. Date : 2008 Aug

PMID : 18820816






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical studies in patients with T2DM have shown that DPP-4 inhibitors reduce elevated A1C, lower postprandial and fasting glucose, suppress glucagon release, and are weight neutral. Glucagon dipeptidyl peptidase 4 Homo sapiens